About Us • News

March 13, 2007

Invirion Launches First Quantitative HPV E6, E7 Assay and Announces CE Mark and Approval for Reimbursement in Spain


OAK BROOK, ILLINOIS-- Invirion Diagnostics, LLC announced today that its highly sensitive HPV screening test HPV OncoTect™ received approval for reimbursement from two of Spain’s largest insurance payors - Sanitas and Aresa. Distributed by Labec Pharma located in Madrid, HPV OncoTect™ is CE marked and available throughout Spain and Portugal. Read article >>

 

October 10, 2006 04:44 PM Eastern Time
Invirion Diagnostics, LLC Announces Release of Newest Reagent Kit

OAK BROOK, Ill.--(BUSINESS WIRE)--In connection with the launch of its new website, Invirion Diagnostics, LLC today announced the release of its newest reagent kit: ViroTect HCV In-Cell Detection Kit. This kit is intended for researchers in the health sciences who are studying cells infected with the hepatitis C virus (HCV). The kit is based on the company’s proprietary technology for labeling specific viral RNA’s inside cells. Since viruses typically live inside cells, Invirion’s assays provide a unique and powerful method for studying viral replication in the cells that they infect and for determining if active viral replication is or is not inhibited by the drugs that are used to treat disease caused by the virus. Read article >>

©2006 Invirion Diagnostics, LLC
Home
| About | HIV | Women's Health | Organ Transplant Related Virology | General Purpose Reagents | Services | Research & Development | Contact | Site Map